AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 135 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,387 | +19.7% | 802,588 | -12.1% | 0.00% | +33.3% |
| Q2 2023 | $2,830 | +198.8% | 912,974 | +34.1% | 0.00% | +200.0% |
| Q1 2023 | $947 | -4.3% | 681,017 | +36.9% | 0.00% | 0.0% |
| Q4 2022 | $990 | -99.9% | 497,474 | +42.4% | 0.00% | -50.0% |
| Q1 2022 | $1,457,000 | +50.2% | 349,320 | +72.4% | 0.00% | +100.0% |
| Q4 2021 | $970,000 | +99.2% | 202,566 | +121.9% | 0.00% | 0.0% |
| Q3 2021 | $487,000 | -61.8% | 91,290 | -63.4% | 0.00% | -50.0% |
| Q2 2021 | $1,276,000 | -63.0% | 249,160 | -51.3% | 0.00% | -60.0% |
| Q1 2021 | $3,444,000 | +677.4% | 511,752 | +348.1% | 0.01% | +400.0% |
| Q3 2020 | $443,000 | -92.8% | 114,213 | -91.1% | 0.00% | -90.9% |
| Q2 2020 | $6,136,000 | +785.4% | 1,289,082 | +546.9% | 0.01% | +450.0% |
| Q1 2020 | $693,000 | -25.8% | 199,263 | +2.9% | 0.00% | 0.0% |
| Q4 2019 | $934,000 | – | 193,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |